HN user

jseliger

85,544 karma

The Story's Story -- http://jakeseliger.com Grant Writing Confidential -- http://www.seliger.com/blog

E-mail: seligerj [@] gmail DOT com.

And I'm somewhat on Twitter now: @seligerj / https://twitter.com/seligerj.

Posts9,171
Comments3,187
View on HN
www.persuasion.community 1y ago

Empty Credentialism Is Hurting Medicine

jseliger
9pts0
www.thetimes.com 1y ago

China is stockpiling – we must do the same

jseliger
43pts27
www.fastcompany.com 1y ago

Why is it so hard for the U.S. to build quality transit?

jseliger
50pts138
www.eater.com 1y ago

Everybody gets a star: Yelp's effect on restaurants and reviews

jseliger
36pts65
www.theatlantic.com 1y ago

In large urban metros, the number of children under 5 is in a free fall

jseliger
6pts0
unherd.com 1y ago

China's Plan to Defeat the West

jseliger
6pts0
www.thebignewsletter.com 1y ago

Non-Competes Might Be Ending?

jseliger
3pts0
erictopol.substack.com 1y ago

The Indomitable Covid Virus: A major wave is occurring now

jseliger
6pts0
commoncog.com 1y ago

A Fine Dining Restaurant in a Recession

jseliger
2pts0
www.noahpinion.blog 1y ago

Why America fell behind in drones, and how to catch up agaon

jseliger
13pts4
www.palladiummag.com 1y ago

The Academic Culture of Fraud

jseliger
5pts0
www.writingruxandrabio.com 1y ago

Elites are mostly lazily well-intentioned

jseliger
7pts3
slate.com 1y ago

How to build U.S. high-speed rail: Lessons from Asia, Europe

jseliger
1pts0
marginalrevolution.com 1y ago

The Unseen Fallout: Chernobyl's Deadly Air Pollution Legacy

jseliger
4pts0
www.statnews.com 1y ago

Malaria vaccines: A 40-year quest against one of humanity's biggest killers

jseliger
3pts0
jakeseliger.com 1y ago

More isn't always better: death and over-treatment as a downside of agenticness

jseliger
3pts1
www.bakerinstitute.org 1y ago

Annexation of Taiwan: A Defeat from Which the US and Allies Could Not Retreat

jseliger
7pts3
www.vanityfair.com 1y ago

El Segundo: California's Freedom-Loving, Bible-Thumping Hub of Hard Tech

jseliger
2pts1
www.curbed.com 1y ago

What NYC Lost When It Lost Congestion Pricing

jseliger
5pts1
thefrisc.com 1y ago

SF's Historic Preservation Rules Are in Limbo, All Part of CA's Push for Housing

jseliger
27pts53
hdsr.mitpress.mit.edu 1y ago

We Should Do More Direct Replications in Science

jseliger
3pts0
ifp.org 1y ago

NEPA Will Tax Clean Energy

jseliger
2pts0
www.power-eng.com 1y ago

Kairos Power begins construction on Hermes molten salt reactor

jseliger
2pts0
www.wsj.com 1y ago

The U.S. Wanted to Knock Down Huawei. It's Only Getting Stronger

jseliger
2pts2
www.noahpinion.blog 1y ago

Why did the U.S. miss the battery revolution?

jseliger
16pts1
www.conspicuouscognition.com 1y ago

Why do people believe true things?

jseliger
3pts0
www.theatlantic.com 1y ago

What adults lost when kids stopped playing in the street

jseliger
95pts107
www.bloomberg.com 1y ago

China Beat the US in the Great EV Race

jseliger
2pts1
www.nytimes.com 1y ago

Germans Combat Climate Change with DIY Solar Panels

jseliger
8pts0
quillette.com 1y ago

The Puzzle of Generational Politics

jseliger
4pts4
Starting Hospice 2 years ago

I hope too to accomplish at least two concrete ends:

1. Help and educate other people who are suddenly facing the opaque clinical-trial system: https://bessstillman.substack.com/p/please-be-dying-but-not-...

2. Ultimately, reform and speed FDA approval for fatal diseases like recurrent / metastatic head and neck cancers: https://jakeseliger.com/2024/01/29/the-dead-and-dying-at-the.... A drug like petosemtamab (MCLA-158), which I was on from Sept. 27 2023 to March 29 2024, should already be approved, instead of continuing to wander around in clinical trials.

Starting Hospice 2 years ago

Hacker News, thank you for all the links and all the great reading. Now I have to say goodbye.

I’m with my wife Bess (https://bessstillman.substack.com/) and my brother Sam, and crying, but it is okay. At the end of Lord of the Rings Gandalf says to the hobbits, "Go in peace! I will not say: do not weep; for not all tears are an evil.” And that is how I feel now. Ending prematurely hurts, but all things must end, and my time to end is upon me.

Every day feels like prison

Dying from cancer makes me feel that way too: https://news.ycombinator.com/context?id=40970295 In my case, I can't really speak any more. Until mid-June I could eat pureed foods, and now I can't even do that.

You only live once. Make some changes. Deepen friendships. Focus on romantic partner. Life is not about you, it's about the people you're with and who are around you.

The biggest question in oncology today is whether this approach could also be used for solid tumors

Yeah. I'm dying of a squamous cell carcinoma infestation: https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-ce... and the most recent clinical trial drug that was working, has stopped working: https://jakeseliger.com/2024/05/20/in-which-the-antibody-dru....

One of the options for a next trial is from TScan, "A Basket Study of Customized Autologous TCR-T Cell Therapies." https://www.clinicaltrials.gov/study/NCT05973487?term=tscan0.... On the one hand, it looks very promising; on the other hand, lots of promising treatments fail during dose-escalation, first-in-human trials. To my knowledge, the first humans dosed with TScan's TCR-T therapy got it a few months ago.

I got lucky, too, in that a slot for BGB-A3055 with Tislelizumab, an immunotherapy drug and trial, opened up at NEXT Oncology-Dallas: https://clinicaltrials.gov/study/NCT05935098?term=BGB-A3055&.... One challenge, however, is that I received a bispecific antibody called petosemtamab from Sept 2023 to March 2024, then PDL1V (an antibody drug conjugate), and they're considered immunotherapies, so there's a question of whether continuing to pursue immunotherapies makes sense. By now the number of lines of therapy I've gotten make me ineligible for some trials: https://bessstillman.substack.com/p/the-drugs-killing-dying-..., and I've also blown through the more promising drugs for what is a difficult-to-treat cancer type.

It took just five years to get from their first promising results to FDA approval

This sentence is insane. "Just?" It should be happening in months, not years. These are people with fatal diagnoses. Having the FDA hold up therapies like this is criminal.

I can't speak for everyone, but ours was great. The other day the car threw an error message about the battery; we brought it to a service center, which swapped the whole battery free under warranty and without bother. Tesla gave my wife $100 in Uber credits per day until they got a loaner a few days later.

Perhaps the best part of the "service experience" is not having to go in for oil changes, brakes, and all the other stuff legacy cars require.

One of my friends passed away earlier this year due to cancer and one of the questions I've kept wondering about has been about our slow progress in curing cancer. (Which admittedly stems from my own utter ignorance on the subject!)

A lot of that "slow progress" is due to the FDA's intransigence and conservatism, even in the face of patients like me who are dying already anyway: https://jakeseliger.com/2023/07/22/i-am-dying-of-squamous-ce...

See also "The dead and dying at the gates of oncology clinical trials" https://jakeseliger.com/2024/01/29/the-dead-and-dying-at-the... and my wife on what trying to enroll in clinical trials is like from the patient's perspective: "Please be dying, but not too quickly: a clinical trial story" https://bessstillman.substack.com/p/please-be-dying-but-not-...

We could and should be moving faster. I'm dying anyway, so if a treatment doesn't work or even harms me, I'm not much worse off than I was before the treatment.

I know of a couple of people I really trust that tried to explain to me how they feel when they try math or programming and it's more like a physical pain almost than frustration.

For a lot of people writing prose is like this too (https://bessstillman.substack.com/p/on-writing-or-not). Back when I taught English to college students, it felt like getting students used to creating the smallest fraction of writing possible—getting them started—was a key skill, as was trying to teach the kind of free association that leads to deeper insights. Learning to manage frustration is of vital import to many people who want or need to learn to write better.